Literature DB >> 29900976

Turkish League Against Rheumatism Consensus Report: Recommendations For Management of Axial Spondyloarthritis.

Hatice Bodur1, Fatma Gül Yurdakul2, Şebnem Ataman3, Yeşim Garip2, Kemal Nas4, Fikriye Figen Ayhan Fikriye Figen Ayhan5,6, Özgür Akgül7, Ayşen Akinci8, Zuhal Altay9, Murat Birtane10, Derya Soy Buğdayci11, Erhan Çapkin12, Remzi Çevik13, Tuncay Duruöz14, Gülcan Gürer15, Cahit Kaçar16, Ayhan Kamanli17, Ece Kaptanoğlu18, Taciser Kaya19, Hilal Kocabaş20, Ömer Kuru21, Meltem Alkan Melikoğlu22, Erhan Özdemirel23, Sumru Özel24, Aylin Rezvani25, İlhan Sezer26, İsmihan Sunar3, Gürkan Yilmaz3.   

Abstract

OBJECTIVES: This study aims to update 2011 Turkish League Against Rheumatism SpondyloArthritis Recommendations, and to compose a national expert opinion on management of axial spondyloArthritis under guidance of current guidelines, and implantation and dissemination of these international guidelines into our clinical practice. PATIENTS AND METHODS: A scientific committee of 28 experts consisting of 14 rheumatologists and 14 physical medicine and rehabilitation specialists (one of them also has an immunology PhD) was formed. The recommendations, systematic reviews, and meta-analyses including pharmacologic and non-pharmacologic treatment were scrutinized paying special attention with convenient key words. The draft of Turkish League Against Rheumatism opinion whose roof consisted of international treatment recommendations, particularly the Assessment of SpondyloArthritis International Society/European League Against Rheumatism recommendations was composed. Assessment of level of agreement with opinions by task force members was established through the Delphi technique. Voting using a numerical rating scale assessed the strength of each recommendation.
RESULTS: Panel compromised on five basic principles and 13 recommendations including pharmacological and nonpharmacological methods. All of the recommendations had adequate strength.
CONCLUSION: Turkish League Against Rheumatism expert opinion for the management of axial spondyloArthritis was developed based on scientific evidence. These recommendations will be updated regularly in accordance with current developments.

Entities:  

Keywords:  Axial spondyloarthritis; comorbidities; exercises; nonpharmacological management; treatment

Year:  2018        PMID: 29900976      PMCID: PMC5864166          DOI: 10.5606/ArchRheumatol.2018.6833

Source DB:  PubMed          Journal:  Arch Rheumatol        ISSN: 2148-5046            Impact factor:   1.472


  47 in total

1.  Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis.

Authors:  Dominique Baeten; Joachim Sieper; Jürgen Braun; Xenofon Baraliakos; Maxime Dougados; Paul Emery; Atul Deodhar; Brian Porter; Ruvie Martin; Mats Andersson; Shephard Mpofu; Hanno B Richards
Journal:  N Engl J Med       Date:  2015-12-24       Impact factor: 91.245

Review 2.  New evidence on the management of spondyloarthritis.

Authors:  Joachim Sieper; Denis Poddubnyy
Journal:  Nat Rev Rheumatol       Date:  2016-04-07       Impact factor: 20.543

3.  Efficacy of oral prednisolone in active ankylosing spondylitis: results of a double-blind, randomised, placebo-controlled short-term trial.

Authors:  H Haibel; C Fendler; J Listing; J Callhoff; J Braun; J Sieper
Journal:  Ann Rheum Dis       Date:  2013-04-26       Impact factor: 19.103

4.  Recommendations of the French Society for Rheumatology (SFR) on the everyday management of patients with spondyloarthritis.

Authors:  Daniel Wendling; Cédric Lukas; Julien Paccou; Pascal Claudepierre; Laurence Carton; Bernard Combe; Philippe Goupille; Francis Guillemin; Christophe Hudry; Corinne Miceli-Richard; Maxime Dougados
Journal:  Joint Bone Spine       Date:  2014-01-10       Impact factor: 4.929

5.  2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.

Authors:  Susan M Goodman; Bryan Springer; Gordon Guyatt; Matthew P Abdel; Vinod Dasa; Michael George; Ora Gewurz-Singer; Jon T Giles; Beverly Johnson; Steve Lee; Lisa A Mandl; Michael A Mont; Peter Sculco; Scott Sporer; Louis Stryker; Marat Turgunbaev; Barry Brause; Antonia F Chen; Jeremy Gililland; Mark Goodman; Arlene Hurley-Rosenblatt; Kyriakos Kirou; Elena Losina; Ronald MacKenzie; Kaleb Michaud; Ted Mikuls; Linda Russell; Alexander Sah; Amy S Miller; Jasvinder A Singh; Adolph Yates
Journal:  J Arthroplasty       Date:  2017-06-16       Impact factor: 4.757

Review 6.  Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis.

Authors:  Johanna Callhoff; Joachim Sieper; Anja Weiß; Angela Zink; Joachim Listing
Journal:  Ann Rheum Dis       Date:  2014-04-09       Impact factor: 19.103

7.  Restrictive pulmonary function is more prevalent in patients with ankylosing spondylitis than in matched population controls and is associated with impaired spinal mobility: a comparative study.

Authors:  Gunnhild Berdal; Silje Halvorsen; Désirée van der Heijde; Morten Mowe; Hanne Dagfinrud
Journal:  Arthritis Res Ther       Date:  2012-01-25       Impact factor: 5.156

8.  Low-dose modified-release prednisone in axial spondyloarthritis: 3-month efficacy and tolerability.

Authors:  Francesca Bandinelli; Francesco Scazzariello; Emanuela Pimenta da Fonseca; Mittermayer Barreto Santiago; Claudio Marcassa; Francesca Nacci; Marco Matucci Cerinic
Journal:  Drug Des Devel Ther       Date:  2016-11-14       Impact factor: 4.162

9.  Anti-IL17A in Axial Spondyloarthritis-Where Are We At?

Authors:  Peter P Cheung
Journal:  Front Med (Lausanne)       Date:  2017-01-18

Review 10.  Managing morbidity and treatment-related toxicity in patients with ankylosing spondylitis.

Authors:  Martin Bergman; Amy Lundholm
Journal:  Rheumatology (Oxford)       Date:  2018-03-01       Impact factor: 7.580

View more
  1 in total

1.  Ankylosing spondylitis: etiology, pathogenesis, and treatments.

Authors:  Xu Cao; Xisheng Weng; Wei Zhu; Xuxia He; Kaiyuan Cheng; Linjie Zhang; Di Chen; Xiao Wang; Guixing Qiu
Journal:  Bone Res       Date:  2019-08-05       Impact factor: 13.567

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.